ERBB2 and gastric cancer: Until now, certain specific markers, including human epidermal growth factor receptor-2 [15, 16], vascular endothelial growth factor receptor 2 [17], excision repair cross-complementation group 1 [18], B-cell lymphoma-2 and Ki-67 [19] have been used for the diagnosis of patients with GC.